Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 18/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2624380 | 0.89 | ELANE (0.61) | ELANE | |
| SCHEMBL10660029 | 0.86 | ELANE (0.57) | ELANE | |
| SCHEMBL5043048 | 0.83 | ELANE (0.63) | ELANE | |
| SCHEMBL6565662 | 0.83 | ELANE (0.58) | ELANE | |
| SCHEMBL12165541 | 0.82 | ELANE (0.56) | ELANE | |
| SCHEMBL6565652 | 0.80 | ELANE (0.74) | ELANE | |
| SCHEMBL10660014 | 0.76 | ELANE (0.68) | ELANE | |
| SCHEMBL29444197 | 0.76 | ELANE (1.00) | ELANE | |
| SCHEMBL13109025 | 0.76 | ELANE (0.59) | ELANE | |
| SCHEMBL146072 | 0.76 | ELANE (1.00) | ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8304538-B2 | Method of producing benzoxazinone-based compound | FUJIFILM CORPORATION (JP) | 2012-11-06 | — | — | US | disclosed |
| US-20110015314-A1 | ULTRAVIOLET ABSORBENT AND PRODUCTION METHOD OF THE SAME | FUJIFILM CORPORATION (JP) | 2011-01-20 | — | — | US | disclosed |
| US-20100256362-A1 | METHOD OF PRODUCING BENZOXAZINONE-BASED COMPOUND | FUJIFILM CORPORATION (JP) | 2010-10-07 | — | — | US | disclosed |
| WO-2009041715-A1 | METHOD OF PRODUCING BENZOXAZINONE-BASED COMPOUND | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | WO | disclosed |
| US-5849820-A | Thermal stabilized resin compositions | KOLON INDUSTRIES, INC. (KR) | 1998-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015314-A1 | ULTRAVIOLET ABSORBENT AND PRODUCTION METHOD OF THE SAME | SLC40A1, F2, SLC19A1 | ELANE 3147/4885 |
| US-20100256362-A1 | METHOD OF PRODUCING BENZOXAZINONE-BASED COMPOUND | SDHA, CYP4X1, SDHB | ELANE 2786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.